Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CFD”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Early research (Phase 1)Study completedNCT05202145
What this trial is testing

Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 61
Not applicableStudy completedNCT04926415
What this trial is testing

Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Obesity and Insulin Resistance

Who this might be right for
Diabetes Mellitus, Type 2Obesity
Burrell College of Health Sciences 30
Not applicableLooking for participantsNCT07315633
What this trial is testing

An Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver Cancer, AdultLiver Cancer
University Hospital, Ghent 80
Testing effectiveness (Phase 2)Ended earlyNCT03459443
What this trial is testing

A Proof of Concept Study for a 12 Month Treatment in Patients With C3G or IC-MPGN Treated With ACH-0144471

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Alexion Pharmaceuticals, Inc. 22
Not applicableUnknownNCT06498830
What this trial is testing

Application of CTA-based Radiomic Phenotyping of PCAT and Fluid Dynamics in Atherosclerotic Disease (APPLE)

Who this might be right for
Computed Tomography AngiographyInflammation of Adipose TissueCFD
Jinling Hospital, China 2,000
Early research (Phase 1)Study completedNCT04660890
What this trial is testing

The Cardiac Effects of ALXN2050 in Healthy Adults

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 39
Not applicableLooking for participantsNCT06115096
What this trial is testing

Cardiac Hemodynamics During Left Ventricular Assist

Who this might be right for
Heart Failure
Region Östergötland 35
Early research (Phase 1)Study completedNCT04935294
What this trial is testing

Study of Danicopan in Participants With Normal Kidney Function and Participants With Kidney Dysfunction

Who this might be right for
HealthyRenal Dysfunction
Alexion Pharmaceuticals, Inc. 16
Large-scale testing (Phase 3)Study completedNCT04469465
What this trial is testing

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Alexion Pharmaceuticals, Inc. 86
Early research (Phase 1)Study completedNCT03555539
What this trial is testing

Study of Danicopan in Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Alexion Pharmaceuticals, Inc. 16
Early research (Phase 1)Study completedNCT04451434
What this trial is testing

Study of Danicopan in Participants of Japanese Descent

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT00966459
What this trial is testing

Computed Tomography (CT) and Lung Function Data Collection for Computational Fluid Dynamics (CFD) in Chronic Obstructive Pulmonary Disease (COPD) Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
University Hospital, Antwerp 20
Early research (Phase 1)Study completedNCT05047458
What this trial is testing

Single-dose ALXN2050 in Healthy Adults

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT03369236
What this trial is testing

A Proof-of-Concept Study of Danicopan for 6 Months of Treatment in Participants With C3 Glomerulopathy (C3G)

Who this might be right for
C3 GlomerulopathyC3 GlomerulonephritisDense Deposit Disease
Alexion Pharmaceuticals, Inc. 13
Not applicableUnknownNCT04428125
What this trial is testing

CFD Analysis and Risk of TOS in Sport

Who this might be right for
Thoracic Outlet SyndromeSport Injury
University of Catanzaro 100
Early research (Phase 1)Study completedNCT03384186
What this trial is testing

Modified Release Formulations of Danicopan in Healthy Adult Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 14
Not applicableUnknownNCT06306729
What this trial is testing

Computational Assessment of Bioprosthetic Aortic Valve Function

Who this might be right for
CFDValve Heart Disease
Royal Brompton & Harefield NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT04889690
What this trial is testing

Study of Multiple Doses of Danicopan in Healthy Participants

Who this might be right for
Healthy
Alexion Pharmaceuticals, Inc. 45
Testing effectiveness (Phase 2)Ended earlyNCT05116774
What this trial is testing

BCX9930 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Participants With Inadequate Response to C5 Inhibitor Therapy

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
BioCryst Pharmaceuticals 12
Not applicableStudy completedNCT07782918
What this trial is testing

Research on Aneurysm Growth Prediction in Vascular Dilation Caused by Bicuspid Aortic Valve Based on VDM and CFD

Who this might be right for
Bicuspid Aortic Valve (BAV)Aortic AneurysmTAVR
Second Affiliated Hospital, Zhejiang University, School of Medicine 1,000
Next Page